Ono Pharmaceutical Co., Ltd. - Product Pipeline Review - 2016

  • ID: 3960455
  • Company Profile
  • 118 pages
  • Global Markets Direct
1 of 5

FEATURED COMPANIES

  • ChemoCentryx, Inc.
  • Jyant Technologies, Inc
  • Polyphor Ltd.
  • MORE
Ono Pharmaceutical Co., Ltd. - Product Pipeline Review - 2016

The report ‘Ono Pharmaceutical Co., Ltd. - Product Pipeline Review - 2016’, provides an overview of the Ono Pharmaceutical Co., Ltd.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Ono Pharmaceutical Co., Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note - : Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope:

- The report provides a snapshot of the pipeline therapeutic landscape of Ono Pharmaceutical Co., Ltd.
- The report provides overview of Ono Pharmaceutical Co., Ltd. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Ono Pharmaceutical Co., Ltd.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Ono Pharmaceutical Co., Ltd.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to Buy:

- Evaluate Ono Pharmaceutical Co., Ltd.’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Ono Pharmaceutical Co., Ltd.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Ono Pharmaceutical Co., Ltd.’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • ChemoCentryx, Inc.
  • Jyant Technologies, Inc
  • Polyphor Ltd.
  • MORE
Introduction

Ono Pharmaceutical Co., Ltd. Snapshot

Ono Pharmaceutical Co., Ltd. Overview

Key Facts

Ono Pharmaceutical Co., Ltd. - Research and Development Overview

Key Therapeutic Areas

Ono Pharmaceutical Co., Ltd. - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Combination Treatment Modalities

Pipeline Products - Partnered Products

Partnered Products/Combination Treatment Modalities

Pipeline Products - Out-Licensed Products

Out-Licensed Products/Combination Treatment Modalities

Ono Pharmaceutical Co., Ltd. - Pipeline Products Glance

Ono Pharmaceutical Co., Ltd. - Late Stage Pipeline Products

Pre-Registration Products/Combination Treatment Modalities

Phase III Products/Combination Treatment Modalities

Ono Pharmaceutical Co., Ltd. - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

Ono Pharmaceutical Co., Ltd. - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

Ono Pharmaceutical Co., Ltd. - Drug Profiles

(carbidopa + levodopa prodrug) - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

abatacept - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

anamorelin hydrochloride - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

E-0001163 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

etelcalcetide hydrochloride - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

ivabradine hydrochloride - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

landiolol - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

metyrosine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Monoclonal Antibody for Autoimmune Disease - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

nivolumab - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

ONO-2952 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

ONO-4059 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

ONO-4127 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

ONO-4232 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

ONO-4310321 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

ONO-4474 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

ONO-7268MX1 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

ONO-7268MX2 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

ONO-8055 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

ONO-8430506 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

ONO-8577 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

opicapone - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

oprozomib - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

salirasib - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecule to Antagonize S1P2 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecule to Inhibit Protease Enzyme for Undisclosed Indication - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecules to Antagonize Lysophosphatidic Acid Receptor 1 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Ono Pharmaceutical Co., Ltd. - Pipeline Analysis

Ono Pharmaceutical Co., Ltd. - Pipeline Products by Target

Ono Pharmaceutical Co., Ltd. - Pipeline Products by Route of Administration

Ono Pharmaceutical Co., Ltd. - Pipeline Products by Molecule Type

Ono Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action

Ono Pharmaceutical Co., Ltd. - Dormant Projects

Ono Pharmaceutical Co., Ltd. - Discontinued Pipeline Products

Discontinued Pipeline Product Profiles

arundic acid

asimadoline

ceralifimod

freselestat

gemilukast

ipilimumab

limaprost

methylnaltrexone bromide

NIP-022

ONO-1266

ONO-2506-PO

ONO-4053

ONO-4127

ONO-5129

ONO-5334

ONO-6126

ONO-8539

remimazolam

rivenprost

tecemotide

Ono Pharmaceutical Co., Ltd. - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

List of Tables

Ono Pharmaceutical Co., Ltd., Key Facts

Ono Pharmaceutical Co., Ltd. - Pipeline by Indication, 2016

Ono Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2016

Ono Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2016

Ono Pharmaceutical Co., Ltd. - Combination Treatment Modalities in Pipeline, 2016

Ono Pharmaceutical Co., Ltd. - Partnered Products in Pipeline, 2016

Ono Pharmaceutical Co., Ltd. - Partnered Products/ Combination Treatment Modalities, 2016

Ono Pharmaceutical Co., Ltd. - Out-Licensed Products in Pipeline, 2016

Ono Pharmaceutical Co., Ltd. - Out-Licensed Products/ Combination Treatment Modalities, 2016

Ono Pharmaceutical Co., Ltd. - Pre-Registration, 2016

Ono Pharmaceutical Co., Ltd. - Phase III, 2016

Ono Pharmaceutical Co., Ltd. - Phase II, 2016

Ono Pharmaceutical Co., Ltd. - Phase I, 2016

Ono Pharmaceutical Co., Ltd. - Preclinical, 2016

Ono Pharmaceutical Co., Ltd. - Discovery, 2016

Ono Pharmaceutical Co., Ltd. - Pipeline by Target, 2016

Ono Pharmaceutical Co., Ltd. - Pipeline by Route of Administration, 2016

Ono Pharmaceutical Co., Ltd. - Pipeline by Molecule Type, 2016

Ono Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action, 2016

Ono Pharmaceutical Co., Ltd. - Dormant Developmental Projects,2016

Ono Pharmaceutical Co., Ltd. - Discontinued Pipeline Products, 2016

Ono Pharmaceutical Co., Ltd., Other Locations

Ono Pharmaceutical Co., Ltd., Subsidiaries

List of Figures

Ono Pharmaceutical Co., Ltd. - Pipeline by Top 10 Indication, 2016

Ono Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2016

Ono Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2016

Ono Pharmaceutical Co., Ltd. - Partnered Products in Pipeline, 2016

Ono Pharmaceutical Co., Ltd. - Pipeline by Top 10 Target, 2016

Ono Pharmaceutical Co., Ltd. - Pipeline by Route of Administration, 2016

Ono Pharmaceutical Co., Ltd. - Pipeline by Molecule Type, 2016

Ono Pharmaceutical Co., Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
- ChemoCentryx, Inc.
- Jyant Technologies, Inc
- Polyphor Ltd.
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll